With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.

Hyderabad: Cancer research is currently undergoing a massive paradigm shift. Once thought to be triggered by a single genetic error, cancer is now understood as a complex and multi-layered ...

A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across ...

Recent developments in the biopharma AI world include an alliance between Thermo and Datavant, plus news from Insilico, Evinova, BPGbio, Evogene, and AMPLY.

Partnership announced as former Queen's University spin-out appoints Dr Oliver Rausch as chief scientific officer ...

Researchers have developed RNA therapeutics, called micelles, that can delivery chemotherapeutic drugs to metastasized tumors in mouse models.

Keeps Biomed backs AI-driven oncology platform as Belfast’s AMPLY appoints new chief scientific officer to accelerate growth ...

QIMR Berghofer scientists have discovered a cancer-fighting RNA molecule that could hold the key to a new way of treating the most common form of breast cancer. The team are developing their findings ...

IPA, a non-coding RNA from the CUL1 gene that stabilizes the nucleolus and supports ribosome production. Removing it disrupted nucleolar structure. Higher CUL1-IPA levels correlated with worse ...

Scientists have identified a key reason why more than half of people with chronic kidney disease eventually die from heart-related conditions. New evidence shows that damaged kidneys release a ...